{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:33:13Z","timestamp":1792290793042,"version":"4.4.0"},"reference-count":25,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T00:00:00Z","timestamp":1469145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>In 2007, the United States\u2013 Food and Drug Administration (FDA) issued guidance concerning animal models for testing the efficacy of medical countermeasures against variola virus (VARV), the etiologic agent for smallpox. Ectromelia virus (ECTV) is naturally-occurring and responsible for severe mortality and morbidity as a result of mousepox disease in the murine model, displaying similarities to variola infection in humans. Due to the increased need of acceptable surrogate animal models for poxvirus disease, we have characterized ECTV infection in the BALB\/c mouse. Mice were inoculated intranasally with a high lethal dose (125 PFU) of ECTV, resulting in complete mortality 10 days after infection. Decreases in weight and temperature from baseline were observed eight to nine days following infection. Viral titers via quantitative polymerase chain reaction (qPCR) and plaque assay were first observed in the blood at 4.5 days post-infection and in tissue (spleen and liver) at 3.5 days post-infection. Adverse clinical signs of disease were first observed four and five days post-infection, with severe signs occurring on day 7. Pathological changes consistent with ECTV infection were first observed five days after infection. Examination of data obtained from these parameters suggests the ECTV BALB\/c model is suitable for potential use in medical countermeasures (MCMs) development and efficacy testing.<\/jats:p>","DOI":"10.3390\/v8070203","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T09:54:45Z","timestamp":1469181285000},"page":"203","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ectromelia Virus Disease Characterization in the BALB\/c Mouse: A Surrogate Model for Assessment of Smallpox Medical Countermeasures"],"prefix":"10.3390","volume":"8","author":[{"given":"Jennifer","family":"Garver","sequence":"first","affiliation":[{"name":"Battelle Biomedical Research Center, West Jefferson, OH 43162, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Weber","sequence":"additional","affiliation":[{"name":"Battelle Biomedical Research Center, West Jefferson, OH 43162, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vela","sequence":"additional","affiliation":[{"name":"Vaccine and Gene Therapy Institute, Oregon Health and Science University, Portland, OR 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Anderson","sequence":"additional","affiliation":[{"name":"Battelle Biomedical Research Center, West Jefferson, OH 43162, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Warren","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority, US Department of Health and Human Services, Washington, DC 20201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Merchlinsky","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority, US Department of Health and Human Services, Washington, DC 20201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8125-4173","authenticated-orcid":false,"given":"Christopher","family":"Houchens","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority, US Department of Health and Human Services, Washington, DC 20201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rogers","sequence":"additional","affiliation":[{"name":"Battelle Biomedical Research Center, West Jefferson, OH 43162, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,7,22]]},"reference":[{"key":"ref_1","unstructured":"Fenner, F., Henderson, D.A., Arita, I., Jezek, Z., and Ladnyi, I.D. (1988). History of International and Public Health, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1586\/14787210.2014.979157","article-title":"Discovery of forgotten variola specimens at the National Institutes of Health in the USA","volume":"12","author":"Arita","year":"2014","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000TM: The new smallpox vaccine for United States Strategic National Stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2217\/fvl.11.27","article-title":"Development of the small-molecule antiviral ST-246\u00ae as a smallpox therapeutic","volume":"6","author":"Grosenbach","year":"2011","journal-title":"Future Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/path.1700330317","article-title":"Infectious ectromelia: A hitherto undescribed virus disease in mice","volume":"33","author":"Marchal","year":"1930","journal-title":"J. Pathol. Bacteriol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1099\/vir.0.81090-0","article-title":"Ectromelia virus: The causative agent of mousepox","volume":"86","author":"Esteban","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/JVI.75.3.1205-1210.2001","article-title":"Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox","volume":"75","author":"Jackson","year":"2001","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0300985810378649","article-title":"Animal models of orthopoxvirus infection","volume":"47","author":"Chapman","year":"2010","journal-title":"Vet. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3390\/v2091918","article-title":"Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics","volume":"2","author":"Parker","year":"2010","journal-title":"Viruses"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-61779-876-4_11","article-title":"Mousepox, a small animal model of smallpox","volume":"890","author":"Esteban","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/153567600400900103","article-title":"Mousepox: A small animal model for biodefense research","volume":"9","author":"Buller","year":"2004","journal-title":"Appl. Biosaf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1099\/0022-1317-68-10-2669","article-title":"A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice","volume":"68","author":"Brenan","year":"1987","journal-title":"J. Gen. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Percy, D.H., and Barthold, S.W. (2007). Mouse. Pathology of Laboratory Rodents and Rabbits, Blackwell Publishing. [3rd ed.].","DOI":"10.1002\/9780470344613"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(02)00199-7","article-title":"A review of compounds exhibiting anti-orthopoxvirus activity in animal models","volume":"57","author":"Smee","year":"2003","journal-title":"Antivir. Res."},{"key":"ref_15","first-page":"148","article-title":"The BALB\/c mouse as a model to study orthopoxviruses","volume":"122","author":"Buller","year":"1985","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Smallwood, S.E., Rahman, M.M., Smith, D.W., and McFadden, G. (2010). Myxoma Virus: Propagation, Purification, Quantification, and Storage. Curr. Protoc. Microbiol., 14A.1.","DOI":"10.1002\/9780471729259.mc14a01s17"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.antiviral.2012.02.005","article-title":"Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox\u2014An animal model of smallpox","volume":"94","author":"Parker","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1128\/JCM.42.2.601-609.2004","article-title":"Smallpox and pan-orthopox virus detection by real-time 3\u2032-minor groove binder TaqMan assays on the Roche LightCycler and the Cepheid Smart Cycler platforms","volume":"42","author":"Kulesh","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/cgt.2013.53","article-title":"Improved cytotoxic T-lymphocyte immune responses to a tumor antigen by vaccines co-expressing the SLAM-associated adaptor EAT-2","volume":"20","author":"Aldhamen","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"ref_20","unstructured":"Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) (2011, January 14\u201315). Antiviral Drugs Advisory Committee Meeting, Silver Spring, MD, USA."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1128\/JVI.01931-10","article-title":"Comparative Analysis of Monkeypox Virus Infection of Cynomologus Macaques by the Intravenous or Intrabronchial Inoculation Route","volume":"85","author":"Johnson","year":"2011","journal-title":"J. Virol."},{"key":"ref_22","unstructured":"Fenner, F., and Buller, R.M. (1997). Viral Pathogenesis, Lippincott-Raven Publishing."},{"key":"ref_23","first-page":"163","article-title":"Techniques for studying murine natural killer cells in defense against viral infection","volume":"121","author":"Scalzo","year":"2000","journal-title":"Methods Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1073\/pnas.1202143109","article-title":"Perforin-dependent CD4+ T-cell cytotoxicity contributes to control a murine poxvirus infection","volume":"109","author":"Fang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6812","DOI":"10.1073\/pnas.111151098","article-title":"Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus","volume":"98","author":"Mahalingam","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/7\/203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:26:49Z","timestamp":1760210809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/7\/203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,22]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7]]}},"alternative-id":["v8070203"],"URL":"https:\/\/doi.org\/10.3390\/v8070203","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,22]]}}}